Nordic countries: Noncommunicable diseases (NCD) country profile
Introduction
This country profile visualizes selected Global Monitoring Framework (GMF) and Progress Monitor (PM) indicators. GMF data are taken from the Global Health Observatory (GHO) and the European health for all (HFA) database . PM indicators assess the implementation of “best buy” (recommended) policies for the governance, surveillance, prevention and management of NCD. Full names and definitions of indicators, as well as data, are given in PM 2015 and PM 2017.
GMF indicators
Outcomes
|
Target 1: 25% relative reduction in the overall mortality from cardiovascular diseases, cancer, diabetes and chronic respiratory diseases |
Unconditional probability of dying between ages of 30 and 70 from cardiovascular diseases, cancer, diabetes or chronic respiratory diseases
Fig.1: Unconditional probability of dying between ages 30 and 69 years from cardiovascular diseases, cancer, diabetes or chronic respiratory diseases by sex, 1990 to latest available data.
Fig.2: Unconditional probability of dying between ages 30 and 69 years from diseases of the circulatory system by sex, 1990 to latest available data.
Fig.3: Unconditional probability of dying between ages 30 and 69 years from cancers by sex, 1990 to latest available data.
Fig.4: Unconditional probability of dying between ages 30 and 69 years from chronic respiratory diseases by sex, 1990 to latest available data.
Fig.5: Unconditional probability of dying between ages 30 and 69 years from diabetes by sex, 1990 to latest available data.
Cancer incidence, by type of cancer, per 100 000 population
Fig.6: Cancer incidence by sex, 1990 to latest available data.
Fig.7: Incidence of trachea, bronchus and lung cancer by sex, 1990 to latest available data.
Fig.8: Incidence of female breast and cervix uteri cancers, 1990 to latest available data.
Behavioural risk factors
|
Target 2: At least 10% relative reduction in the harmful use of alcohol, as appropriate, within the national context |
Total (recorded and unrecorded) alcohol per capita (aged 15+ years old) consumption within a calendar year in litres of pure alcohol, as appropriate, within the national context
Fig.9: Total (recorded and unrecorded) adult alcohol per capita consumption, 1990 to latest available data.
Age-standardized prevalence of heavy episodic drinking among adolescents and adults, as appropriate, within the national context
Fig.10: Age-standardized heavy episodic drinking (defined as 60 grams or more of pure alcohol on at least one occasion in the past 30 days) among adults aged 15 years or more with 95% confidence intervals, latest available data (WHO estimates).
|
Target 5: A 10% relative reduction in prevalence of insufficient physical activity |
Age-standardized prevalence of insufficiently physically active persons aged 18+ years (defined as less than 150 minutes of moderate-intensity activity per week, or equivalent)
Fig.11: Age-standardized prevalence of insufficient physical activity among adults aged 18+ years, latest available data (WHO estimates).
|
Target 5: A 30% relative reduction in prevalence of current tobacco use |
Age-standardized prevalence of current tobacco use among persons aged 18+ years
Fig.12: Age-standardized prevalence of current tobacco smoking among people aged 15 years and over, latest available data (WHO estimates).
Biological risk factors
|
Target 6: A 25% relative reduction in the prevalence of raised blood pressure or contain the prevalence of raised blood pressure, according to national circumstances |
Age-standardized prevalence of raised blood pressure among persons aged 18+ years and mean systolic blood pressure
Fig.13: Age-standardized prevalence of raised blood pressure, defined as systolic blood pressure greater or equal to 140 mmHg and/or diastolic blood pressure greater or equal to 90 mmHg, 1990 to latest available data (WHO estimates).
Fig.14: Age-standardized mean systolic blood pressure, 1990 to latest available data (WHO estimates).
|
Target 7: Halt the rise in diabetes & obesity |
Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years
Fig.16: Age-standardized prevalence of raised blood glucose or diabetes among persons aged 18+ years with 95% confidence intervals, 1990 to latest available year (WHO estimates).
Age-standardized prevalence of overweight and obesity in persons aged 18+ years
Fig.17: Age-standardized prevalence of overweight among persons aged 18+ years, 1990 to latest available data (WHO estimates).
Fig.18: Age-standardized prevalence of obesity among persons aged 18+ years, 1990 to latest available data (WHO estimates).
Additional indicators
Fig.19: Age-standardized prevalence of raised total cholesterol with 95% confidence interval among people aged 15 years and over, latest available data (WHO estimates).
Fig.20: Age-standardized mean total cholesterol with 95% confidence interval, latest available data (WHO estimates).
Fig.21: Proportion of infants vaccinated against hepatitis B.